Bml Capital Management, LLC Aclaris Therapeutics, Inc. Transaction History
Bml Capital Management, LLC
- $161 Billion
- Q4 2024
A detailed history of Bml Capital Management, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 14,250,000 shares of ACRS stock, worth $35.5 Million. This represents 21.95% of its overall portfolio holdings.
Number of Shares
14,250,000
Previous 14,250,000
-0.0%
Holding current value
$35.5 Million
Previous $16.4 Billion
115.65%
% of portfolio
21.95%
Previous 9.64%
Shares
4 transactions
Others Institutions Holding ACRS
# of Institutions
80Shares Held
48.6MCall Options Held
30.6KPut Options Held
1K-
Vanguard Group Inc Valley Forge, PA4.69MShares$11.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.37MShares$8.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.01MShares$7.48 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.75MShares$6.86 Million0.11% of portfolio
-
Stonepine Capital Management, LLC Bend, OR2.46MShares$6.12 Million1.79% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $166M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...